The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A review of interventional clinical trials (CTs) in renal cell carcinoma (RCC): A status report from the ClinicalTrials.gov website.
Matthew R. Zibelman
No relevant relationships to disclose
Peter Barth
No relevant relationships to disclose
Elizabeth Handorf
No relevant relationships to disclose
Marc C. Smaldone
No relevant relationships to disclose
Alexander Kutikov
No relevant relationships to disclose
Robert G. Uzzo
No relevant relationships to disclose
Marijo Bilusic
No relevant relationships to disclose
Elizabeth R. Plimack
No relevant relationships to disclose
Yu-Ning Wong
No relevant relationships to disclose
Daniel M. Geynisman
No relevant relationships to disclose